Cardiac Care 5-Year
Horizon Project Report
Background Cardiac
Introduction Cardiology Issues and
  1. Leape LL. Park RE. Bashore TM. Harrison JK. Davidson CJ. Brook RH. Effect of variability in the interpretation of coronary angiograms on the appropriateness of use of coronary revascularization procedures. American Heart Journal. 2000; 139 (1 Pt 1): 106-113.
  2. Squires S. Secrets of the heart. Washington Post. 2000 Aug 8; Page Z12 Section: Health.
  3. Grines CL. Cox DA. Stone GW. Garcia E. Mattos LA. Giambartolomei A. Brodie BR. Madonna O. Eijgelshoven M. Lansky AJ. O'Neill WW. Morice MC. Coronary angioplasty with or without stent implantation for acute myocardial infarction. Stent Primary Angioplasty in Myocardial Infarction Study Group. New England Journal of Medicine. 1999; 341(26): 1949-1956.
  4. Katz S. Green SJ. Kaplan BM. Chepurko L. Goldner BG. Ong L. Nonrandomized comparison between stent deployment and percutaneous transluminal coronary angioplasty in acute myocardial infarction. American Heart Journal. 2000; 139 (1 Pt 1): 44-51.
  5. Goldschlager NF. Ryan T. Wenger NK. Acute MI: New therapies, new directions. Patient Care. 1999; 33(8): 88-114.
  6. Stone GW. Brodie BR. Griffin JJ. Morice MC. Costantini C. St. Goar FG. Overlie PA. Popma JJ. McDonnell J. Jones D. O'Neill WW. Grines CL. Prospective, multicenter study of the safety and feasibility of primary stenting in acute myocardial infarction: in-hospital and 30-day results of the PAMI stent pilot trial. Primary Angioplasty in Myocardial Infarction Stent Pilot Trial Investigators. Journal of the American College of Cardiology. 1998; 31(1): 23-30.
  7. Faxon DP. Heger JW. Primary angioplasty - enduring the test of time. New England Journal of Medicine. 1999; 341(19): 1464-1465.
  8. Zijlstra F. Hoorntje JC. de Boer MJ. Reiffers S. Miedema K. Ottervanger JP. van'T Hof AW. Suryapranata H. Long-term benefit of primary angioplasty as compared with thrombolytic therapy for acute myocardial infarction. New England Journal of Medicine. 1999; 341(19): 1413-1419.
  9. Lauer MS. Primary angioplasty - time is of the essence. JAMA. 2000; 283(22): 2988-2989.
  10. Cucherat M. Bonnefoy E. Tremeau G. Primary angioplasty versus intravenous thrombolysis for acute myocardial infarction. Cochrane Database of Systematic Reviews. (2): CD001560, 2000.
  11. Shubrooks SJ Jr. Malenka DJ. Piper WD. Bradley WA. Watkins MW. Ryan TJ. Hettleman BD. VerLee PN. O'Meara JR. Robb JF. Kellett MA. Hearne MA. McGrath PD. Wennberg DE. O'Rourke DJ. Silver TM. Safety and efficacy of percutaneous coronary interventions performed immediately after diagnostic catheterization in northern New England and comparison with similar procedures performed later. American Journal of Cardiology. 2000; 86(1): 41-45.
  12. Bucher HC. Hengstler P. Schindler C. Guyatt GH. Percutaneous transluminal coronary angioplasty versus medical treatment for non-acute coronary heart disease: meta-analysis of randomized controlled trials. BMJ. 2000; 321(7253): 73-77.
  13. Scanlon PJ, Faxon DP, Audet AM, Carabello B, Dehmer GJ, Eagle KA, Legako RD, Leon DF, Murray JA, Nissen SE, Pepine CJ, Watson RM. ACC/AHA Practice Guidelines for Coronary Angiography: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Coronary Angiography). Journal of the American College of Cardiology 1999; 33: 1756-1816.
  14. Ryan TJ, Bauman WB, Kennedy JW, Kereiakes DJ, King III SB, McCallister BD, Smith Jr. SC, Ullyot DJ. Guidelines for Percutaneous Transluminal Coronary Angioplasty: ACC/AHA Task Force Report. Journal of the American College of Cardiology 1993; 22: 2033-2054.
  15. American Heart Association. 2000 heart and stroke statistical update. Dallas, TX: American Heart Association, 1999.
  16. Pitt B. Waters D. Brown WV. van Boven AJ. Schwartz L. Title LM. Eisenberg D. Shurzinske L. McCormick LS. Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease. Atorvastatin versus Revascularization Treatment Investigators. New England Journal of Medicine. 1999; 341(2): 70-6.
  17. Adele C. Vaitkus PT. Wells SK. Zehnacker JB. Cost advantages of an ad hoc angioplasty strategy. Journal of the American College of Cardiology. 1998; 31(2): 321-325.
  18. Cannon CP. Gibson CM. Lambrew CT. Shoultz DA. Levy D. French WJ. Gore JM. Weaver WD. Rogers WJ. Tiefenbrunn AJ. Relationship of symptom-onset-to-balloon time and door-to-balloon time with mortality in patients undergoing angioplasty for acute myocardial infarction. JAMA. 2000; 283(22): 2941-2947.
  19. Gibbons RJ, Chatterjee K, Daley J, Douglas JS, Fihn SD, Gardin JM, Grunwald MA, Levy D, Lytle BW, O'Rourke RA, Schafer WP, Williams SV. ACC/AHA/ACP-ASIM guidelines for the management of patients with chronic stable angina: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients with Chronic Stable Angina). J Am Coll Cardiol 1999; 33:2092-197.
  20. Jencks SF. Cuerdon T. Burwen DR. et al. Quality of medical care delivered to Medicare beneficiaries: A profile at state and national levels. JAMA. 2000; 284(13): 1670-1676.
  21. Dudley RA. Johansen KL. Brand R. et al. Selective referral to high-volume hospitals: estimating potentially avoidable deaths. JAMA. 2000; 283: 1159-1166.
  22. Gregory PM. et al. New Jersey cardiac surgery capacity study: Access to cardiac surgery services.
  23. Wenneker MB. Epstein AM. Racial inequalities in the use of procedures for patients with ischemic heart disease in Massachusetts. JAMA. 1989; 261(2): 253-257.
  24. Weintraub WS. We don't have the cure yet: ten-year follow-up after angioplasty. Journal of Invasive Cardiology. 1999; 11(12): 729-731.
  25. Hannan. EL. Kilburn H Jr. Bernard H. et al. Coronary artery bypass surgery. Medical Care. 1991; 29: 1094-1107.
  26. Hannan EL. Racz M. Ryan TJ. et al. Coronary angioplasty volume-outcome relationships for hospitals and cardiologists. JAMA. 1997; 277(11): 892-898.
  27. Rosamond WD. Chambless LE. Folsom AR. Survival trends, coronary event rates, and the MONICA project. The Lancet. 1999; 354(9181): 864-865.
  28. Pohost GM. Biederman RW. Doyle M. Cardiovascular magnetic resonance imaging and spectroscopy in the new millennium. Curr Probl Cardiol. 2000; 25(8): 525-620.
  29. Winslow R. Hensley S. FDA is ready to approve new heart therapy. Wall Street Journal. 2000 Nov. 3.

Report Cover


NJ Home Search NJ NJ Departments NJ Services NJ Directories NJ Legislature NJ Judiciary